Atrovent
Atrovent is also known as Ipratropium, an anti-cholinergic drug that is often used to treat obstructive lung diseases. The drug works by barring muscarinic receptors found in the lungs. This will cause inhibition of mucus secretion and bronchoconstriction. Atrovent does not diffuse into our blood which is a good thing because it can prevent systemic side effects.
Bronchospasm attacks are often treated with Atrovent but this will not take effect on the individual if the attack is happening. You will need to recover from the attack or before it for Atrovent to work properly. There may also be other diseases that Atrovent is called for to treat or alleviate other than those listed above. Regular use of Atrovent for patients who suffer from emphysema, COPD, and bronchospasm will help reduce the risk of attacks and manage the condition.
Atrovent is sometimes integrated or combined with salbutamol or fenoterol to manage COPD and asthma. This drug is best taken via inhalation for fast and effective results. Inhalers are handy and precise dispensers of drugs and medications for those who need them. Be careful exposing your Atrovent container to heat since extreme heat can cause it to burst open. It is important to bear in mind that you would have to discard the inhaler after spraying it 200 times even if
you feel that there is still some medication left in the canister.
Atrovent Restrictions
Having narrow angle glaucoma or an enlarged prostate may prevent you from using Atrovent. Your doctor may alternatively, lower or adjust the dosage of Atrovent to fit the condition of the person who suffers from bronchospasms. Children under twelve years of age may not be given Atrovent as medication to treat their condition. Women who are pregnant or are planning to be within the period of treatment using Atrovent must consult their doctor regarding this. Although, there are no conclusive studies regarding the effects of Atrovent on an unborn child or breastfeeding it is best to be sure of everything before taking the drug.
Using Atrovent
Using the inhaler Atrovent is very convenient. Before initial use, prime the inhaler by blasting it a couple of times in the air. If you have not used your inhaler for over three days, prime it also. When using the inhaler, uncap the canister and breathe out slowly, put the valve into your mouth and close your eyes to be sure not to spray your eyes. Breathe in slowly at the same time push down the button.
Hold your breath for around 7 – 10 seconds before breathing out again.
ATROVENT NEWS HIGHLIGHTS
- Inhaler lung drugs tied to heart problems, deaths
(AP) - Study: 70,000 may suffer post-9/11 stress disorder
(AP) - Health Tip: Pregnancy and Asthma
(HealthDay) - Health Tip: Pregnancy and Asthma
(HealthDay) - Epilepsy Drug May Prevent, Treat Alzheimer’s
(HealthDay) - Health Tip: Allergies and Your Eyes
(HealthDay) - Kids’ eye problems often emerge in homework battle
(AP) - Kids’ eye problems often emerge in homework battle
(AP) - FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
- FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
- UN urges Indonesia to stop imprisoning drug users
(AP) - Some depressed patients opt for assisted suicide
(Reuters) - FDA launches plan to curb accidental overdoses
(AP) - FDA launches plan to curb accidental overdoses
(AP) - Pain drug morphine may accelerate cancer growth
(Reuters) - Pain drug morphine may accelerate cancer growth
(Reuters) - For Older Walkers, Faster Is Better
(HealthDay) - For Older Walkers, Faster Is Better
(HealthDay) - Gains Against Heart Failure Reported
(HealthDay) - Health Tip: Treating a Sinus Headache
(HealthDay) - Health Tip: Treating a Sinus Headache
(HealthDay) - Nycomed Announces FDA Filing for Daxas in COPD
- Plavix Plus Heartburn Drugs May Hike Heart Risk
(HealthDay) - Health Tip: Taking ADHD Medications
(HealthDay) - Health Tip: Taking ADHD Medications
(HealthDay) - COPD raises risk of depression: study
(Reuters) - Postnatal depression can be treated, prevented: studies
(AFP) - Cutting Parkinson’s Drug Dose Linked to Withdrawal Effects
(HealthDay) - Cutting Parkinson’s Drug Dose Linked to Withdrawal Effects
(HealthDay) - Govt pushes electronic family tree for good health
(AP) - Experts promote baldness drug for prostate cancer
(Reuters) - FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
- Rituxan Approved for Chronic Lymphocytic Leukemia
(HealthDay) - Rituxan Approved for Chronic Lymphocytic Leukemia
(HealthDay) - Rituxan Approved for Chronic Lymphocytic Leukemia
(HealthDay) - Rituxan Approved for Chronic Lymphocytic Leukemia
(HealthDay) - Nausea Drug Shows Promise Against Opioid Addiction
(HealthDay) - Nausea Drug Shows Promise Against Opioid Addiction
(HealthDay) - Health Tip: Help Reduce Your Risk of Lung Disease
(HealthDay) - Benicar Approved for Kids With High Blood Pressure
(HealthDay) - Benicar Approved for Kids With High Blood Pressure
(HealthDay) - Glaucoma Drugs May Play Role in Longer Life
(HealthDay) - Study: Gender gap remains for heart attack care
(AP) - Study: Sticking with heart rehab boosts survival
(AP) - Study: Sticking with heart rehab boosts survival
(AP) - Documents Provide Glimpses Of Ivins’ State Of Mind
- Internet program helps diabetics monitor sugar
- PSI HIV/AIDS Program Reaches Out To Prisoners In Mexico
- Stopping A Killer: LUMEN 2009 Looks To Establish National Protocol For Treating Heart Attack Patients
- Health Buzz: California Ruling Protects Gays and Other Health News